Keyphrases
Liver Transplantation
100%
Calcineurin Inhibitors
100%
Primary Biliary Cholangitis
100%
Tacrolimus
70%
Adjusted Hazard Ratio
60%
Graft Loss
40%
Patient Survival
30%
Low Risk
30%
Mycophenolate Mofetil
30%
High Risk
20%
Reassurance
20%
Non-associated
20%
Immunosuppressive Drugs
20%
Cyclosporine
20%
Mycophenolate
20%
European Liver Transplant Registry
20%
Graft Survival
20%
Donation after Brain Death
20%
Adult Patients
10%
Potential Gains
10%
Combination Therapy
10%
Combination Treatment
10%
Long-term Survival
10%
Survival Analysis
10%
Donor Age
10%
Recipient Age
10%
Continued Use
10%
Post-liver Transplantation
10%
Long-term Graft Survival
10%
Model Maintenance
10%
Recipient Sex
10%
Recipient Survival
10%
Medicine and Dentistry
Liver Transplantation
100%
Calcineurin Inhibitor
100%
Primary Biliary Cirrhosis
100%
Tacrolimus
70%
Hazard Ratio
60%
Graft Failure
40%
Mycophenolate Mofetil
30%
Recurrent Disease
20%
Liver Graft
20%
Cyclosporine
20%
Reassurance
20%
Brain Death
20%
Immunosuppressive Drug
20%
Mycophenolic Acid
20%
Combination Therapy
10%
Survival Analysis
10%
Event Free Survival
10%
Long Term Survival
10%
Pharmacology, Toxicology and Pharmaceutical Science
Calcineurin Inhibitor
100%
Primary Biliary Cirrhosis
100%
Tacrolimus
70%
Graft Failure
40%
Mycophenolate Mofetil
30%
Immunosuppressive Agent
20%
Recurrent Disease
20%
Ciclosporin
20%
Brain Death
20%
Mycophenolic Acid
20%
Long Term Survival
10%
Event Free Survival
10%
Combination Therapy
10%
Immunology and Microbiology
Liver Transplantation
100%
Primary Biliary Cirrhosis
100%
Tacrolimus
70%
Mycophenolate Mofetil
30%
Immunosuppressive Drug
20%
Mycophenolic Acid
20%
Ciclosporin
20%
Long Term Survival
10%
Event Free Survival
10%